Breaking

fda

User Blocked After Repeated Policy Violations
Research Drops

User Blocked After Repeated Policy Violations

Retatrutide access opens as Eli Lilly launches a compassionate‑use program for patients unable to join clinical trials, awaiting FDA approval soon.

Florinda Ashbridge · August 6, 2026
Internet users report widespread access blocks
Research Drops

Internet users report widespread access blocks

CDC links thousands of Cyclospora outbreak cases to Taco Bell lettuce. Follow the latest updates on the foodborne illness investigation involving Taylor…

Zenobia Fairweather · August 1, 2026
User Blocked by Social Media Platform
Research Drops

User Blocked by Social Media Platform

FDA rejects Capricor's deramiocel for Duchenne muscular dystrophy treatment due to lack of effectiveness evidence, based on phase 3 trial findings.

Zenobia Fairweather · July 31, 2026
User access restricted after policy breach
Research Drops

User access restricted after policy breach

The FDA approved Simtriyo, a new ADHD medication for adults and children, improving focus and emotional regulation with extended-release benefits.

Florinda Ashbridge · July 28, 2026